• Mouse Tissue Lysis Kit (K1038): Practical Workflow Guide

  2026-08-04

  The Mouse Tissue Lysis Kit (K1038) addresses bottlenecks in research workflows by enabling rapid, direct lysis of mouse tissues for genotyping assays and DNA analysis. It eliminates the need for traditional extraction and purification steps, but is not suitable for diagnostic or clinical applications.

• Magnetic Stimulation Downregulates Gabre to Reverse SCZ Beha

  2026-08-04

  The referenced study demonstrates that selective magnetic stimulation targeting the left prelimbic cortex downregulates the GABAA receptor ε subunit (Gabre), reversing schizophrenia-like behaviors and synaptic deficits in mouse models. These findings highlight Gabre modulation as a promising neuromodulatory target for advancing noninvasive brain stimulation therapies in schizophrenia research.

• Caspase-3 Colorimetric Assay Kit: Protocols, QC, and Trouble

  2026-08-03

  The Caspase-3 Colorimetric Assay Kit provides a streamlined, sensitive method to quantitatively detect DEVD-dependent caspase-3 activity, a key marker of apoptosis. It is best suited for cell and tissue lysates in apoptosis and neurodegeneration research workflows, but is not intended for non-caspase protease assays or direct in vivo imaging applications.

• Redefining cDNA Synthesis for Translational Research: HyperS

  2026-08-03

  This thought-leadership article explores the mechanistic and strategic advantages of HyperScript™ Reverse Transcriptase for translational researchers tackling complex RNA templates. Blending molecular insight with practical guidance, it examines the enzyme’s M-MLV heritage, its validation in advanced qPCR workflows, and the evolving standards for RNA to cDNA conversion—grounding every claim in peer-reviewed literature and real-world protocols. The discussion escalates beyond typical product descriptions, offering a roadmap for researchers aiming to bridge discovery and clinical impact.

• Ibrexafungerp and Caspofungin Against Fluconazole-Resistant

  2026-08-02

  Wiederhold et al. present robust in vitro and in vivo evidence that ibrexafungerp, a novel oral triterpenoid, effectively combats fluconazole-resistant Candida auris, even when treatment is delayed. The study benchmarks ibrexafungerp against caspofungin, highlighting the importance of β-(1,3)-D-glucan biosynthesis inhibition in antifungal strategies for multidrug-resistant Candida infections.

• Electrostatic Partitioning in α-Synuclein Condensates: Charg

  2026-08-01

  This study reveals that α-synuclein condensates possess a pronounced negative electrostatic potential, critically influencing the partitioning of molecules and dye-labeled proteins. These findings establish a foundational link between condensate surface charge and molecular distribution, offering new directions for investigating protein phase behavior and disease mechanisms.

• Thioguanine: Epigenetic Innovation in Cancer and Antiviral R

  2026-07-31

  Explore how Thioguanine, a potent thiopurine immunosuppressant, uniquely enables advanced epigenetic and antiviral research through dual DNMT1 and HGPRT targeting. This article uncovers mechanistic insights and practical assay guidance not found in standard application guides.

• ARCA Cy5 EGFP mRNA (5-moUTP): Elevating Delivery & Localizat

  2026-07-31

  ARCA Cy5 EGFP mRNA (5-moUTP) empowers researchers with real-time, dual-fluorescent tracking of mRNA uptake and translation in mammalian cells, streamlining both optimization and troubleshooting of delivery workflows. Its 5-methoxyuridine chemistry and Cy5 label establish a new benchmark for quantitative, immune-evasive mRNA assays.

• Targeted mRNA Nanoparticles Restore BBB After Ischemic Strok

  2026-07-30

  The referenced study introduces a lipid nanoparticle-based mRNA delivery system targeting M2 microglia to treat blood–brain barrier (BBB) disruption post-ischemic stroke. By promoting IL-10-driven microglial polarization, this approach attenuates neuroinflammation and fosters neurological recovery, marking a significant advance in mRNA therapeutics for CNS injury.

• Capsazepine: Advanced TRPV1 Antagonism for Nociception and C

  2026-07-30

  Explore how Capsazepine, a potent TRPV1 ion channel antagonist, enables precise dissection of pain and apoptosis pathways. This article delivers in-depth analysis, protocol guidance, and practical insights for researchers seeking to advance TRPV1 channel function research.

• One-step TUNEL FITC Apoptosis Detection Kit: Applied Workflo

  2026-07-29

  The One-step TUNEL FITC Apoptosis Detection Kit enables precise, high-throughput detection of apoptosis in tissue sections and cultured cells, streamlining DNA fragmentation assays for complex disease models. Its robust performance, validated in both cancer and vascular remodeling research, empowers rapid, quantitative analysis of cell death dynamics in experimental workflows.

• GRA12: A Pan-Strain Virulence Factor in Toxoplasma gondii In

  2026-07-29

  This study identifies GRA12 as a conserved, essential virulence factor required for acute Toxoplasma gondii infection across diverse parasite strains and mouse subspecies. By leveraging pooled in vivo CRISPR-Cas9 screens, the research reveals GRA12’s central role in parasite survival and immune evasion, with implications for host-pathogen interaction studies and assay development.

• Reserpine (N1867): Practical Guidelines for Lab Research Use

  2026-07-28

  Reserpine (SKU N1867) is a high-purity natural product standard used for reliable neurotransmitter depletion research and antihypertensive mechanism studies. It should be handled using strict preparation and storage protocols to ensure reproducibility, and is not suitable for clinical, diagnostic, or veterinary applications.

• HyperScript™ Reverse Transcriptase: Unraveling RNA Complexit

  2026-07-28

  Explore how HyperScript™ Reverse Transcriptase empowers researchers tackling RNA templates with complex secondary structures, particularly in adipogenesis and metabolic pathway studies. Discover unique assay design insights grounded in the latest scientific literature and practical protocol guidance.

• Five-Element Nanoparticles Enable Stable, Lung-Targeted mRNA

  2026-07-27

  The referenced study introduces five-element nanoparticles (FNPs) that combine helper-polymer PBAEs and DOTAP to achieve lung-specific mRNA delivery with unprecedented long-term stability after lyophilization. This innovation addresses major barriers in mRNA therapeutics by enhancing both the physical stability and organ-targeting specificity of mRNA delivery systems, offering practical implications for the development and storage of mRNA medicines.

16267 records 1/1085 page Next 12345 下5页 Last page